Dread Disease

Information from the Issuer Company on the acquisition or disposal by a major shareholder under Article 172 of the Cyprus Stock Exchange and Securitie
Proxy for exercise of voting rights
Re-composition of the Committees of the Board of Directors of Hellenic Bank Public Company Ltd
Total number of voting rights and capital
Period and procedure of voluntary conversion of the contingent capital securities 2 ("CCS 2") of Hellenic Bank Public Company Limited
Appointment of new External Auditors for the Financial Year 2021
Proxy for exercise of voting rights of DEMETRA INVESTMENT PUBLIC LTD
Announcement pursuant to section 137 of the Cyprus Securities and Stock Exchange Law of 1993
Listing of new ordinary shares resulting from the Voluntary Conversion of Contingent Capital Securities 2 (“CCS 2”)
Decisions of the Board of Directors of Hellenic Bank Public Company Ltd following the 45th Annual General Meeting of the Shareholders of the Bank – ID
Date of the Board Meeting of Hellenic Bank Public Company Ltd for examining the Financial Results of the Group for the 6month period ended 30/09/2019
Addendum to Disclosures in accordance with Pillar III of Basel III for the year ended 31 December 2018
Withdrawal of candidacy for election as Member of the Board of Directors of Hellenic Bank Public Company Ltd at the AGM of the Shareholders of the Ban
Withdrawal of candidacy for election as Member of the Board of Directors of Hellenic Bank Public Company Ltd at the AGM of the Shareholders of the Ban
Financial Results of the Group of Hellenic Bank Public Company Ltd for the six-month period ended 30th June 2019
Conclusion of a Share-Purchase Agreement for the acquisition of Hellenic Alico Life Insurance Company Limited shares
Annual Financial Report of the Group for the year 2018
Decisions of the Board of Directors of Hellenic Bank Public Company Ltd following the 45th Annual General Meeting of the Shareholders of the Bank
Change in the composition of the Audit Committee of the Board of Directors of Hellenic Bank Public Company Ltd
Period and procedure of voluntary conversion of the contingent capital securities 1 ("CCS 1") of Hellenic Bank Public Company Limited
Announcement of the date for examination of the Audited Financial Statements of the Group for the year ended 31 December 2018
Successful Completion of Capital Increase and Listing of New Ordinary Shares
Successful Share Capital Increase of €150m
Dispatch of the Allotment Letters
ECB approves inclusion of 3Q2018 profit, including negative goodwill, in the Group's regulatory capital
Voluntary Conversion of Contingent Capital Securities 2 (“CCS 2”) into shares
Voluntary Conversion of Contingent Capital Securities 1 (“CCS 1”) into shares
Share Capital Increase - Approval and Publication of Prospectus
Capital Raise - Update on investor subscription agreements
Financial Results of the Group 9M 2018
Period and procedure of voluntary conversion of the contigent capital securities 1 ("CCS 1")
Period and procedure of voluntary conversion of the contigent capital securities 1 ("CCS 1")
Period and procedure of voluntary conversion of the contigent capital securities 2 ("CCS 2")
Period and procedure of voluntary conversion of the contigent capital securities 2 ("CCS 2")
Date of announcement of Financial Results for the nine-month period ended 30/09/2018
Mastercard Rally
Trading update for the financial results for the nine-month period ended 30 September 2018
Announcement for COBALT
New overdraft facilities transferred to Hellenic Bank
Financial Results of the Group 6M 2018
Completion of Acquisition of Assets and Liabilities of the CCB
Date of the Board Meeting for Half Year 2018 Results
Decisions of the EGM
Re-composition of the existing Committees
Subscription agreement with Emma Alpha Holding Ltd
Notice for Extraordinary General Meeting
Establishment of Integration Committee of the BoD
Commission for the Protection of Competition Decision
Decisions of BoD after the 44th AGM
Decisions of the 44th AGM
Withdrawal of candidacy for re-election as Member of BOD
Proxy to Mr. Nicos Michaelas and Mr. Varnavas Irinarchos for DEMETRA INVESTMENT PUBLIC LTD
CSR Report of Hellenic Bank for 2017
Agreement to acquire certain assets and liabilities of the CCB
Proxy to Mr. Nicolaos Pelides for THIRD POINT HELLENIC RECOVERY FUND L.P
Notice for the Annual General Meeting
Acceptance of Hellenic Bank's final offer
Submission of Final Offer
Voluntary Conversion of the CCS1 & CCS2
Completion of the disposal of a portfolio of NPLs
Financial Results of the Group 3M 2018
Notice for Extraordinary General Meeting and Proxy Form
Date of the Board Meeting examining Q1 Results
Submission of Offer through Tender Process
Disclosure of Information under Pillar ΙΙΙ of Basel III
Date of the 44th Annual General Meeting
Report of the BoD on Corporate Governance for 2017
Notification from the Issuer Company on the acquisition or disposal by a major shareholder under Article 172 of CSE and Sec. Law
Disclosure of Information under Pillar III of Basel III for the year 2018
Notice for EGM for amendments to the Articles of Association of the Bank
Annual Report for 2017
Participation in Tender Process 2
Financial Results of the Group for the 9M period ended 30 Sept. 2019
Information from the Issuer Company on the acquisition or disposal by a major shareholder
Voluntary Conversion of Contingent Capital Securities 1 (“CCS 1”) into shares
Resignation of Vice-Chairman and Member of the Board of Directors of Hellenic Bank Public Company Limited
Financial Results of the Group of Hellenic Bank Public Company Ltd for the three-month period ended 31st March 2019
Update on Hellenic Bank deposit interest rates of non-households customers’ accounts
Update on deposit interest rates of non-households customers’ accounts
Voluntary Conversion of Contingent Capital Securities 2 (“CCS2”) into shares of Hellenic Bank Public Company Limited for the period 15-31 January 2020
Decisions of the Extraordinary General Meeting of the Shareholders of Hellenic Bank Public Company Ltd
Notice for Extraordinary General Meeting of Hellenic Bank Public Company Limited for amendments to the Articles of Association of the Bank
Decisions of the 45th Annual General Meeting of the Shareholders of Hellenic Bank Public Company Limited
Notification from the Issuer Company on the acquisition or disposal by a major shareholder under Article 172 of CSE and Sec. Law
New Proposed Candidate for Election / Withdrawal of Candidacy for Re-election
Completion of the Share-Purchase Agreement for the acquisition of Hellenic Alico Life Insurance Company Limited
Voluntary Conversion of Contingent Capital Securities 2 (“CCS 2”) into shares
Corporate Social Responsibility Report of Hellenic Bank Public Company Ltd for the year 2018
Appointment of Mr Kristofer Richard Kraus to the Board of Directors of Hellenic Bank Public Company Limited
Report of the BoD on Corporate Governance for the year 2018
Voluntary Conversion of Contingent Capital Securities 1 (“CCS1”) into shares of Hellenic Bank Public Company Limited for the period 15-31 January 2020
Notice for the Annual General Meeting of Hellenic Bank Public Company Ltd and Proxy Form
Date of the BoD Meeting for examining the results for the 9M period ended 30th Sept. 2019
Approval by the European Central Bank of the appointment of Mr Christos Themistocleous to the Board of Directors of Hellenic Bank Public Company Ltd
Date of the EGM and change of date of the 45th AGM
Change of date of the 45th Annual General Meeting of Hellenic Bank Public Company Limited
Proxy for exercise of voting rights
Announcement of the Date of the Board Meeting of Hellenic Bank Public Company Ltd for examining the Financial Results for the First Quarter of 2019
Annual Report of Hellenic Bank Public Company Ltd for the year 2018
Date of the 45th AGM of the Shareholders
Change in the composition of the Integration Committee of the Board of Directors of Hellenic Bank Public Company Ltd
Decisions of the Extraordinary General Meeting of the Shareholders of Hellenic Bank Public Company Ltd
Participation in Tender Process
Annual Financial Report for 2017
Date of the 44th Annual General Meeting
Date of the Board Meeting for the examination of the Audited Financial Statements
Premilimary Results for 2017
Date of the Board Meeting regarding Premilimary Results
Appointment of new Executive Officer
Agreement between Hellenic Bank and EBRD
Agreement to sell a portfolio of non-performing loans
Completion of Voluntary Early Exit Scheme
Voluntary Conversion CCS1 and CCS2
Έχεις τη δύναμη

Agreement HB - CCB

New overdraft facilities transferred to Hellenic Bank
Completion of Acquisition of Assets and Liabilities of the CCB
Agreement to acquire certain assets and liabilities of the CCB
Acceptance of Hellenic Bank's final offer
Submission of Final Offer

Recognition

Our Awards

News & Insights /portalserver/hb-en-portal/en/about-us/news--insights

Need to speak to somebody

Customer suggestions and complaints
Book an appointment

Help me with ...

Our locations /portalserver/hb-en-portal/en/about-us/our-locations

FAQs

Scholarships 2019 /portalserver/hb-en-portal/en/about-us/jumpstart

Personal Banking
Insure
Life insurance
Dread Disease

Hellenic Life

Dread Disease and Permanent Total Disability Plan

Get immediate cover when you need it.

Key features and benefits

Low premium

Monthly premium payment with direct debit

Fast and simple procedures to join

Show all features

Dread diseases covered:

Cancer

Heart Attack / Myocardial Infraction

Kidney Failure

Stroke

Coronary Artery Bypass Grafting

Aorta Surgery

Blindness

Heart Valve Surgery

Major Organ Transplant

Paralysis

Benign Brain Tumour

Encephalitis

Coma

Loss of Limbs

Severe Burns

Parkinson’s Disease

Loss of Hearing

Loss of Speech

Bacterial Meningitis

Fulminant Hepatitis

Permanent Total Disability due to Disease or Accident

Age at entry: 18-55 (age at last birthday)

Duration: renewable until the 65th year insured

Key features

In the case of diagnosis (or operations due to) one of the twenty dread diseases listed, or permanent total disability, the insured individual will collect:

Premium: €10 monthly - Cover: €15.000
Premium: €20 monthly - Cover: €30.000
Medical Examinations: Not necessary